Stamford, Connecticut, United States The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Stamford.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the ALS Finding a Cure, startups are often financed by Techammer, OS Fund, NanoDimension. The meaningful sponsors for the fund in investment in the same round are Techammer, OS Fund, NanoDimension. In the next rounds fund is usually obtained by ALS Investment Fund, Starlight Ventures, SciFi VC.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Health Care, Pharmaceutical. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Emulate
Related Funds
| Fund Name | Location |
| Abacus Research | Sankt Gallen, Sankt Gallen, Switzerland |
| Albion Investors | New York, New York, United States |
| Allure Media | Australia, New South Wales, Sydney |
| GreenSky Capital | Canada, Ontario, Toronto |
| HDFC Trustee | - |
| Immobiliare.it | Italy, Lazio, Rome |
| JWD Group | Bangkok, Krung Thep, Thailand |
| Light Silver Capital | Beijing, China, Haidian |
| Mayfly Capital, LLC | Boston, Massachusetts, United States |
| National SME Development Fund | China, Guangdong, Shenzhen |
| Quercus Trust | New York, New York, United States |
| SIAT | China, Guangdong, Shenzhen |
| Stony Lonesome Group | Connecticut, United States, Wilton |
| Synaitken | - |
| The eFactory | Missouri, Springfield, United States |
| Trilon | - |
| Warhawk Ventures | - |
| Yxassets.com | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Emulate | $17M | 20 Oct 2016 | Boston, Massachusetts, United States | ||
Amylyx Pharmaceuticals | $3M | 20 Jul 2016 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Emulate | $17M | 20 Oct 2016 | Boston, Massachusetts, United States | ||
Amylyx Pharmaceuticals | $3M | 20 Jul 2016 | Cambridge, Massachusetts, United States |
